Table 1. Patients characteristics.
| Non-COVID-19 | COVID-19 | p-Value | |
|---|---|---|---|
| n = 185 | n = 212 | ||
| Age—years | 72.36 (17.34) | 65.19 (16.29) | <0.001 |
| <30 | 5 (2.7) | 2 (0.9) | |
| 30–40 | 8 (4.3) | 15 (7.1) | |
| 40–50 | 10 (5.4) | 21 (9.9) | |
| 50–60 | 15 (8.1) | 39 (18.4) | |
| 60–70 | 25 (13.5) | 46 (21.7) | |
| 70–80 | 39 (21.1) | 50 (23.6) | |
| 80–90 | 59 (31.9) | 26 (12.3) | |
| >90 | 24 (13.0) | 13 (6.1) | |
| Gender | |||
| Male | 103 (55.7) | 161 (75.9) | <0.001 |
| Comorbidities | |||
| Systemic Arterial Hypertension | 93 (50.3) | 112 (52.8) | 0.683 |
| Diabetes | 50 (27.0) | 54 (25.5) | 0.813 |
| Morbid Obesity | 4 (2.2) | 16 (7.5) | 0.027 |
| Chronic Renal Failure | 29 (15.7) | 17 (8.0) | 0.026 |
| Dyslipidemia | 43 (23.2) | 59 (27.8) | 0.353 |
| Coronary Heart Disease | 29 (15.7) | 37 (17.5) | 0.734 |
| Hypothyroidism | 42 (22.7) | 35 (16.5) | 0.153 |
| Immunosuppression | 31 (16.8) | 16 (7.5) | 0.007 |
| Hematologic Malignancy | 17 (9.2) | 6 (2.8) | 0.013 |
| Solid Tumor | 42 (22.7) | 17 (8.0) | <0.001 |
| COPD | 11 (5.9) | 3 (1.4) | 0.030 |
| Asthma | 4 (2.2) | 6 (2.8) | 0.918 |
| Alcoholism | 3 (1.6) | 4 (1.9) | 1.000 |
| Charlson Comorbidity Score | <0.001 | ||
| 0 | 53 (28.6) | 114 (53.8) | |
| 1–3 | 68 (36.8) | 70 (33.0) | |
| 3–11 | 64 (34.6) | 28 (13.2) | |
| SAPS-3 | 55.63 (11.94) | 49.65 (12.19) | <0.001 |
| SOFA score on day 1 | 4.48 (3.11) | 3.78 (3.53) | 0.039 |
Data are presented as mean (SD) or frequency (proportions).
COPD: Chronic Obstructive Pulmonary Disease, SAPS-3: Simplified Acute Physiology Score, SOFA: Sequential Organ Failure Assessment.